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Abstract
Background: We completed a scoping review on the barriers and facilitators to use of systematic reviews by health
care managers and policy makers, including consideration of format and content, to develop recommendations for
systematic review authors and to inform research efforts to develop and test formats for systematic reviews that
may optimise their uptake.
Methods: We used the Arksey and O’Malley approach for our scoping review. Electronic databases (e.g.,
MEDLINE, EMBASE, PsycInfo) were searched from inception until September 2014. Any study that identified barriers or
facilitators (including format and content features) to uptake of systematic reviews by health care managers and policy
makers/analysts was eligible for inclusion. Two reviewers independently screened the literature results and abstracted
data from the relevant studies. The identified barriers and facilitators were charted using a barriers and facilitators
taxonomy for implementing clinical practice guidelines by clinicians.
Results: We identified useful information for authors of systematic reviews to inform their preparation of reviews
including providing one-page summaries with key messages, tailored to the relevant audience. Moreover, partnerships
between researchers and policy makers/managers to facilitate the conduct and use of systematic reviews should be
considered to enhance relevance of reviews and thereby influence uptake.
Conclusions: Systematic review authors can consider our results when publishing their systematic reviews. These
strategies should be rigorously evaluated to determine impact on use of reviews in decision-making.
Keywords: Systematic reviews, Determinants of knowledge uptake
Background
Knowledge syntheses are comprehensive and reproducible
evidence reviews that summarise all relevant studies on a
question [1]. They can include traditional systematic
reviews and scoping reviews, amongst others. Knowledge
translation (KT) focusing on the results of individual stud-
ies may be misleading due to bias in their conduct or ran-
dom variations in findings [2]. Knowledge syntheses that
interpret the results of individual studies within the context
of global evidence should be considered as the founda-
tional unit of KT, as they interpret the results of individual
studies within the context of the totality of evidence and
are less susceptible to bias than single studies [3]. Know-
ledge syntheses, such as systematic reviews, provide the
evidence base for implementation vehicles, such as patient
decision aids and clinical decision aids clinical practice
guidelines and policy [3]. For example, our research team
conducts knowledge syntheses for the nationally funded
Drug Safety and Effectiveness Network whereby we
complete knowledge synthesis to answer questions posed
by our provincial and national policy makers [4, 5].
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There have been several models or classifications of
evidence (or knowledge) use [6–13]. Larsen described
conceptual and behavioural knowledge use [7]. Concep-
tual knowledge use refers to using knowledge to change
the way users think about issues. Instrumental knowledge
use refers to changes in action as a result of knowledge
use. Dunn categorised knowledge use by describing that it
could be done by the individual or a collective [8]. Weiss
also described several frameworks for knowledge use,
including the problem solving model, which she described
as the direct application of the results of a study to a deci-
sion [9]. She further described this as using knowledge as
“ammunition” [9]. Beyer and Trice labelled this type of
knowledge use as symbolic, which they added to Larsen’s
framework [10]. Symbolic use involves the use of research
as a political or persuasive tool. Estabrooks described a
similar framework for knowledge use including direct,
indirect, and persuasive research utilisation, where these
terms are analogous to instrumental, conceptual, and sym-
bolic knowledge use, respectively [11].
We find it useful to consider conceptual, instrumental
and persuasive knowledge use [6, 12]. Conceptual use of
knowledge implies changes in knowledge, understanding,
or attitudes. Research could change thinking and inform
decision-making but not change behaviour. Instrumental
knowledge use is the concrete application of knowledge
and describes changes in behaviour, for example [6]. Evi-
dence can be translated into a usable form, such as a care
pathway, guideline, or policy, and is used in making a spe-
cific decision. Persuasive knowledge use is also called stra-
tegic or symbolic knowledge use and refers to research
being used as a political or persuasive tool. It relates to the
use of knowledge to attain specific power or profit goals
(i.e. knowledge as ammunition) [6, 12].
Use of evidence by policy makers and managers can
include any of these approaches. Oliver and colleagues
have argued that the concept of knowledge use is further
complicated in the policy context because research evi-
dence is just one form of knowledge that informs decision-
making. They also pose that researchers need to understand
what influences and constitutes policy to better understand
what evidence is required and how it can be used [13].
Despite advances in the conduct and reporting of sys-
tematic reviews and recognition of their importance in
health care decision-making, current evidence suggests
that they are infrequently used by health care managers
and policy makers [14, 15]. Failure of health systems to
optimally use high-quality research evidence results in
inefficiencies, reduced quantity and quality of life, and
lost productivity [16, 17]. As just one example of this
issue, glucose self-testing by older patients with diabetes
who use oral hypoglycemic agents has been identified as
unnecessary and potentially harmful to patients in sys-
tematic reviews [18]. However, financial reimbursement
for glucose test strips for these patients continues in
many countries, costing just one province in Canada $40
million per year [19].
We previously conducted a knowledge synthesis [20]
to identify interventions to encourage use of systematic
reviews by health policy makers and health care man-
agers and identified four articles. Three of these articles
described one study in which five systematic reviews
were mailed to public health officials and followed up
with surveys [21–23]. The authors found that 23 to 63 %
of survey respondents reported using the systematic re-
views to inform policy making decisions. The fourth
study was a randomised trial of tailored messages com-
bined with access to a registry of systematic reviews and
showed a significant effect on policies made in the area
of health body weight promotion by health departments
[24]. In more recent systematic reviews [25, 26], no add-
itional studies were identified that assessed interventions
to increase uptake of systematic reviews by health care
managers and policy makers.
Given that systematic reviews are less susceptible to
bias than a single primary study or the opinions of
experts, it is not clear why they are not used routinely in
decision-making. Two systematic reviews of barriers and
facilitators to the use of systematic reviews by any type
of decision-maker (e.g. clinicians, patients, managers)
identified many factors that contribute to paucity of use
including lack of relevance of the questions the reviews
are addressing, lack of contextualisation of findings,
unwieldy size of the report, and poor presentation
format; these factors can be considered intrinsic to the
systematic review [25, 27]. The format of systematic re-
views has been a key factor identified to influence their
use by policy makers and managers [28]. While attention
has been paid to enhance the quality of systematic re-
views, relatively little attention has been paid to their
format. For example, health care managers and policy
makers would benefit from highlighting information that
is relevant for their decisions including contextual fac-
tors affecting local applicability and information about
costs [27]. And, because reporting of systematic reviews
tends to focus on methodological rigour rather than
context, they often do not provide crucial information
for decision-makers. Other barriers to use of reviews by
health care managers and policy makers include factors
extrinsic to the review, such as lack of access and time
to seek and acquire systematic reviews and lack of skills
to appraise and apply the evidence [27, 29].
Surveys and interviews with policy makers and managers
have identified the importance of increasing the usability of
systematic reviews in decision-making [30, 31]. Under-
standing how to make systematic reviews more usable
requires consideration of barriers and facilitators to their
use, as well as of their format and content. As such, we
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completed a scoping review on the barriers and facilitators
to use of systematic reviews including consideration of for-
mat and content by health care managers and policy
makers to develop recommendations for systematic review
authors and to inform research efforts to develop and test
formats for systematic reviews that may optimise uptake.
This project arose directly from our decision-maker part-
ners, for whom we conduct knowledge syntheses. This
review is part of a multi-phase project to develop and test-
ing a format for a systematic review to optimise use.
Methods
We conducted a scoping review [32] using guidance
from the Joanna Briggs Methods Manual for Scoping
Reviews [33]. A protocol was prepared and revised using
input from our key stakeholders. Although the PRISMA
Statement has not been modified for scoping reviews,
we used it to guide reporting [34].
Data sources and search
We searched the following electronic databases from
inception until week 3 of September 2014: MEDLINE,
EMBASE, PsycInfo, The Cochrane Database of System-
atic Reviews, Cochrane Central Register of Controlled
Trials, CINAHL, and LISA (Library and Information
Science Abstracts). The literature searches for the previ-
ous reviews [20, 26] were peer-reviewed by an information
scientist and modified as necessary. The full literature
search for MEDLINE is available in Additional file 1, and
the other database searches are available from the corre-
sponding author upon request. The search strategy was
not limited by study design or language of dissemination.
The grey literature was searched using Google after identi-
fying key websites (such as websites of funding agencies
and health care provider organisations in Canada, the
USA, and the UK that fund or conduct systematic re-
views). We supplemented the literature search by scan-
ning references of included articles and relevant,
published systematic reviews [20, 25–27, 29]. We also
conducted a forward citation search in the Web of Science
whereby we used the included studies to identify other po-
tentially relevant studies. The results of the literature
search were imported into Synthesi.SR [35], which was
used for screening by the review team.
Study selection: inclusion criteria
Eligible studies included health care managers (defined
as an individual in a managerial or supervisory role in a
health care organisation with management and supervis-
ory mandates, including public health officials) or policy
makers/analysts (defined as an individual (non-elected)
at some level of government; they may have some
responsibility for analysing data and making recommen-
dations to others and may include regional, provincial,
or federal representation) as participants. The focus of
the review was on policy/management decision-making;
however, clinical decision-making articles were included
if policy decision-making was also mentioned and these
data could be abstracted. Often the policy articles con-
sidered clinical decision-making as well, given that this
is often a downstream consideration. For example, if the
policy makers felt that clinicians would not implement
the evidence, this would be eligible for inclusion. Studies
that identified barriers or facilitators (including format
and content features) to uptake of systematic reviews by
health care managers and policy makers/analysts were
eligible for inclusion. All study designs including qualita-
tive or quantitative methodologies where there was a
description of the barriers or facilitators to use of evi-
dence from systematic reviews by the relevant end-user
groups were eligible. Specifically, we included systematic
reviews, experimental (randomised controlled trials, quasi-
randomised controlled trials, non-randomised controlled
clinical trials), quasi-experimental (controlled before after
studies, interrupted time series), observational (cohort, case
control, cross-sectional), and qualitative studies. If more
than one publication described a single study presenting
the same data, we included the most recent. Studies con-
ducted in any setting or country and those published in
any language were eligible for inclusion.
Study selection: screening
To ensure reliability, a calibration exercise with reviewers
was conducted prior to commencing screening. Using the
eligibility criteria, a random sample of 10 % of citations
from the search were screened independently by all re-
viewers. Screening only began when percent agreement
was >90 % across the review team. A similar calibration
exercise was completed prior to screening full-text articles
for inclusion. Subsequently, two reviewers independently
reviewed titles and abstracts and full-text articles for
inclusion. Conflicts were resolved through discussion.
Data abstraction
Two reviewers independently reviewed each full-text
article and extracted relevant data. Data were extracted
on study design, participants, country, barriers, and facil-
itators to use of the systematic review. Differences in
abstraction were resolved by discussion. We did not
assess risk of bias of individual studies because our aim
was to map the evidence, as is consistent with the pro-
posed scoping review methodology [32, 33].
Data charting and collation
The barriers and facilitators were charted using a
taxonomy of barriers and facilitators to implementation
of clinical practice guidelines by clinicians [36]. This
taxonomy was expanded to include attributes of the
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systematic review, specifically its format and content,
and was reviewed by a health care manager to ensure
face validity. The taxonomy was based on a systematic
review of barriers and facilitators to evidence use by cli-
nicians as no similar review was available explicitly for
policy makers and managers at the time we completed
our review. We shared the taxonomy with our decision-
maker partners to assess for face validity and no add-
itional categories were identified. Two reviewers
reviewed each article and identified the unit of text rele-
vant to each of these factors using a coding scheme they
developed. Qualitative analysis was conducted using
NVivo 10 [37]. Codes were aggregated by themes,
centred on whether the barriers/facilitators influenced
participants’ attitudes towards; knowledge of; skills in
seeking, appraising or using; or use of systematic reviews
in decision-making. Discrepancies in coding were dis-
cussed by the team to achieve consensus.
Consultation
Team members (including representatives from the
health care managers and policy makers/analysts from
the Ontario Ministry of Health and Long-term Care)
were consulted at various stages of the scoping review to
provide input on the search, data abstraction, and inter-
pretation of the results.
Results
Literature search
A total of 6635 titles and abstracts and 201 full-text arti-
cles was assessed for eligibility. Subsequently, 19 studies
reported in 21 publications fulfilled the eligibility criteria
and were included [21–24, 30, 31, 38–52]. The reasons
for excluding full-text articles are provided in Fig. 1.
Characteristics of the included articles
All but one of the studies was published after 2000. Au-
thors of the papers were commonly from Canada,
Australia, and the UK. Nineteen of the publications were
qualitative studies, 1 study was quantitative and de-
scribed the impact of an intervention to facilitate use of
systematic reviews, and 1 was a systematic review. A de-
scription of included studies is provided in Table 1.
Barriers to use of systematic reviews
Barriers to the use of systematic reviews are presented in
Table 2. We have also presented the results per study
identified and present this in Additional file 2.
Attitudes
Factors limiting the use of systematic reviews through
an affective component were considered as those bar-
riers that affected attitudes towards the use of systematic
reviews [36]. Lack of agreement with the usefulness of
systematic reviews in general and lack of agreement with
results of specific systematic reviews were identified as
such barriers [21, 44, 50]. With regard to the former,
participants believed that systematic reviews may chal-
lenge their autonomy in decision-making because the
evidence in the review would dictate their decisions and
this was perceived to be a barrier to their use. Lack of
outcome expectancy was also a barrier to use whereby
participants believed that decisions based on systematic
reviews would not lead to the desired outcome because
they did not believe the causal inference implied by the
results of the review [45]. Lack of motivation to change
or resistance to change was a barrier to use of systematic
reviews [51]. Barriers related to lack of agreement with
results of specific systematic reviews were also noted
and included features such as participants’ lack of agree-
ment with the evidence interpretation, their lack of con-
fidence in the authors of the review, or their belief that
the results of the review are not valid [21].
Knowledge
Factors limiting adherence through a cognitive component
were considered knowledge barriers to use of systematic
reviews [36]. For example, participants reported the lack of
awareness or lack of familiarity with a systematic review as
influencing use. Particular challenges related to this factor
included the tremendous volume of information required
for participants to stay abreast of in relevant areas, the lack
of knowledge on how to access relevant systematic reviews,
and the lack of awareness of the importance of systematic
reviews [24, 43, 44].
Skills
Factors limiting adherence to systematic review evidence
through a lack of ability were considered barriers related
to skills [36]. Participants reported the lack of skills to
find, assess, interpret, or use systematic reviews in
decision-making [44, 47, 52]. Additional elements
included the lack of ability to reconcile patient prefer-
ences with recommendations.
Behaviour
Several behavioural barriers to use of systematic reviews
were reported, and these focused on external barriers to
their use, including patient and clinician factors. For
example, patient and clinician resistance to implement-
ing the evidence outlined in the systematic review may
lead to policy makers and managers being reluctant to
use the evidence. Participants also reported factors in-
trinsic to the systematic review as barriers to their use,
including the presence of contradictory results from
different systematic reviews or difficulty accessing
reviews and in particular, difficulty identifying their key
messages quickly when they are needed for decision-
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making [39, 44, 47]. Extrinsic or environmental barriers
were identified including lack of time and organisational
constraints, which prevent the individual from imple-
menting the review. In one of the intervention studies
that were included, lack of time and availability of rele-
vant systematic reviews were identified as barriers to use
in decision-making by public health officials [21, 42, 44].
Facilitators to use of systematic reviews
Facilitators to the use of systematic reviews are presented
in Table 3.
Attitudes
Participants identified that agreement with the useful-
ness of systematic reviews, belief in their relevance, and
their applicability to policy facilitated their use. Partici-
pants perceived systematic reviews were useful if they
had confidence in the review authors [47, 52]. Enthusiasm
and motivation to change were facilitators for use of
systematic reviews; in particular, if important and relevant
reviews could be provided to policy makers at key points in
decision-making, this was perceived to be influential in
their further use [23, 47, 51].
Knowledge
Familiarity or awareness of systematic reviews were poten-
tial facilitators of their use. In particular, knowledge of
their importance relative to single primary studies [31].
Skills
Participants reported that skills in seeking, appraising,
and interpreting systematic reviews facilitated their use
[22, 23, 30]. For example, training in basic searching
skills was identified as a facilitator [52].
Fig. 1 Study flow diagram
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Table 1 Study Characteristics of Included Studies
Studies [reference] Country Study design Setting Type of end user or
participant
Number of end users
or participants
Albert 2007 [38] Mali Qualitative study National government:
pharmaceutical decision-
making group
Health policy maker 19





for a workforce or
national policy
9
Atack 2010 [40] Canada Qualitative study Different health care settings
(research hospital, community
hospital, community health























Ciliska 1999 [21] Canada Qualitative study Public health organisations Health care managers
and total, 277 were
eligible, 242 participated
in the first survey; 225
participated in the
second survey
Dobbins 2001a (CR to Ciliska 1999) [22] Canada Qualitative study
Dobbins 2001b (CR of Ciliska 1999) [23] Canada Qualitative study





Dobbins 2004 [31] Canada Qualitative study Public health (programme
managers, directors,
epidemiologists, medical
officers of health, provincial























Table 1 Study Characteristics of Included Studies (Continued)
Dobbins 2009a [24] Canada RCT Public health departments Health care manager 108
Jewell 2008 [44] USA Qualitative study Conference attendees Health policy maker 28 (11—public health;
15—legislators;
2—both)
Lavis 2005 [45] Canada, Scotland, Norway,
UK
Systematic review and qualitative study Studies of decision-making by
health care managers and





17 studies and 29
participants











Ritter 2009 [46] Australia Qualitative study Drug policy units Health policy maker 31 participants
Rosenbaum 2011 [47] Norway, Argentina, China,
Colombia, South Africa, and
Uganda
Qualitative study National or international
health service or policy-
related work in health
departments, national
insurance programmes,








3 pharmacists, 6 public
health consultants,









Suter 2011 [49] Canada Qualitative study Provincial health authority Health care managers
and policy makers
13 participants






Uganda, and South Africa
Qualitative study National policy organisations Health care managers
and policy makers
112 respondents
Yousefi-Nooraie 2009 [51] Iran Qualitative study Capacity building workshop

















Table 2 Barriers to use of systematic reviews by policy makers and health care managers
Attitudes Knowledge Skills Behaviour








Lack of skills SRs/intrinsic factors Extrinsic factors
Limited quantity of research
on topics of importance to























The review itself did not appear
to be user-friendly due to in
accessible language and dense
layout [39]
Policy inconsistency within health
care system (differing interests,
different policies run in parallel,
performance based incentives) [48]
Systematic reviews do not
necessarily frame the existing
evidence in terms of their
policy applications [44]
Information overload




The health agency staff had not
been taught “to continue to use
research to inform their decisions,
to inform their practice. They
therefore made decisions based
on “common sense”, “gut level”,
“standards of practice”, and
comparative convenience and
awareness of available data, rather
than based on systematic reviews
of research.” [44, 52]
Accessibility: within a systematic
review, have difficulty identifying
key messages [44]
Attacks on an evidence-based
approach. Several officials also
discussed instances in which the
whole notion of evidence-based
health care had come under direct
attack, usually by pharmaceutical
companies, sometimes in collabor
ation with advocacy groups, some
of which hid their involvement
with industry [44].
Lack of or unknown credibility








Lack features that would make
them easier for government
officials to evaluate. For example,
the quality of studies is often
difficult for non-experts to interpret
because the explanation of
research methods is long and
complicated [44]
Concepts presented in tables,
including those that showed the
GRADE assessment and different
levels of risk, were not clear [47]
Accessibility. Even when evidence
is available, policymakers may
have problems obtaining it [44]
Ethical disagreement [21] Appraising and synthesising the
evidence was seen as an even
bigger challenge [40]
Tables running over 2 pages
were cumbersome to read [47]
Lack of availability of research
results [21]
Research information not
valued at community level [21] Difficult to understand by





Lack of resources to implement
research [21]
Policy decisions are made
based on other factors like
cost and equity considerations,
particularly if evidence base is
frail [52]
Words like “sample size”
and “relative risk” would
be difficult to interpret [47]
Use of jargon and/or unfamiliar
vocabulary [47]
Policy climate—provincial/regional
not conducive to use [21]
Mismatch between the type
of content offered and their
information needs [47]
Lack of expertise in
evaluating SRs [44]
Numbers in the text and those
in the tables do not correspond
precisely [47]













Table 2 Barriers to use of systematic reviews by policy makers and health care managers (Continued)
Translating evidence to the
local context (including sub
groups of patients): individuals
frequently had to make
independent decisions about
how to relate evidence to
the needs of their local
context, discuss and debate
the evidence with local
stakeholders and take





seen as an even
bigger challenge [40]
Current practice patterns lead
policy makers and managers
reluctant to use reviews [21]
Policymakers expected
content lying outside
the scope of a review:
recommendations, outcome
measurements not usually
included in a review, detailed
information about local
applicability or costs, and
a broader framing of the
research enquiry [47]
Wanted a shorter, clearer
presentation [47]
Cost of retrieving information
prohibitive [21]
Reviews covered issues at a
more complex level than
required [52]
Insufficient authority to implement
research results [21]
Lack of detail on how to use
strategies, tools, processes that
would lead to successful
integration (i.e. guidance on
breaking down systems barriers
or how to achieve integration in
the context of big, complex
system) [49]
Policy makers had difficulty
finding brief research summaries
and systematic reviews when
they were needed (i.e. difficulty
accessing SRs) [42]
Tended not to use the full
report instead referring to the
less dense, more accessible
articles [49]
Limited time to find, retrieve,
read, and translate research
[21, 24, 47]
Wanted a shorter, clearer
presentation [47]
Research often published in
academic sources, poorly
accessible to policy makers, LMIC
policy makers have limited access
to subscription-based K or the
internet [47]
Lack of indexing local journals in
international databases,
harmonised reporting criteria,
editorial processes and presentation












Table 2 Barriers to use of systematic reviews by policy makers and health care managers (Continued)
standards for reporting of research
for all local journals. Coverage and
searching quality of databases of
papers published in local language
needs improvement, single national
database for research registration,
technical and professional support
for current databases [51]
If department within
commissioning organisation is
not in a position of strength,
unlikely that evidence will be
used for decision-making [52]
Lack of time to find or discuss
evidence, usually need an
answer to a problem on the
same day [52]
Finding the evidence was
described as problematic. Several
fellows called for greater access
to systematic reviews; this was
a resource they wanted to see
augmented through the
desktop [40]
Policy makers’ belief that searching,
accessing, and reviewing research
findings are highly time
consuming is perhaps a good




Limited time to read full study













Table 3 Facilitators to use of systematic reviews by policy makers and health care managers
Attitudes Knowledge Skills Behaviour
Agreement/usefulness Motivation Awareness/familiarity Expertise/experience/training SRs/intrinsic factors Extrinsic factors
Stakeholders described
potential uses of the




internally, to promote a
particular intervention
approach and to identify
gaps of where further
evaluation was needed
[39, 41, 42]
Expecting to use the systematic
reviews in the future [23]
Recognition of relative
importance of SR compared
to other sources of
information such as single
studies (culture of evidence-
based decision-making) [31]
One’s age [23]—younger,
more likely to use
Delineating the effects for
a particular group with
more focused subgroup
analyses in SRs [44]
enhanced their usefulness
Making decisions in collaboration
with other community
organisations increased
likelihood of using reviews [23]
SRs to provide guidance
and suggestions for
implementation of findings,
not just reporting facts [43]
Willingness of health care
providers to use systematic
reviews [51]





about the benefits, harms
(or risks), and costs [45]
Increasing the opportunities for
interaction and exchange
between policy makers and
researchers is key to promoting
the use of research evidence in
policy [42]
Most policy makers r
eported having needed
the data and reviews in
the past 12 months, having
commissioned research or
reviews during this period,
and having used evidence
to contribute to the
content of policy [42]
Perception that reviews facilitate
critical appraisal of evidence
and are easy to use, information
about what works and clearly
articulated implications for policy
(costs, applicability, impacts on
equity) [47]
Providing training in basic
search skills may increase
use [52]
Concise statements about
lives or money can infuse
the political discussion
with a tone of rationality,
framing the trade-offs as
technical and straightforward
[44]. Providing information
about the benefits, harms
(or risks), and costs [45]
One-to-one interaction with the
researcher to discuss research
findings [43]
Respondents who expected
to use the reviews in the
future were more likely to
have used a review than
those who did not expect
to use the reviews [22]
Presenting selected important
systematic reviews to policy






the barrier of limited critical
appraisal skills [22]
Identify attributes of the
context in which the research
included in a systematic
review was conducted to
inform assessments of the
applicability of the review in
other contexts [45]. Concise
statements about lives or
money can infuse the political
discussion with a tone of
rationality, framing the trade-
offs as technical and
straightforward [44]. Providing
information about the
benefits, harms (or risks), and
costs [45]
Organisational research culture
[23, 24] favouring use of




Ongoing training in critical
appraisal of research
literature [23]
Add additional local value to
any type of systematic review
by using language that is
locally applicable and by
engaging in discussions about
the implications of reviews
with the health care managers
Fund production and updating
of SRs with additional resources
for health care managers and
policy makers to interact and













Table 3 Facilitators to use of systematic reviews by policy makers and health care managers (Continued)
and policy makers who could
potentially act on the reviews’
take-home messages [45].
Identify attributes of the
context in which the research
included in a systematic review
was conducted to inform
assessments of the applicability
of the review in other contexts
[45]. Concise statements about
lives or money can infuse the
political discussion with a tone
of rationality, framing the trade-






and reviews in the past
12 months, having
commissioned research
or reviews during this
period, and having used
evidence to contribute
to the content of
policy [42]
Opportunities for training and
education on systematic
reviews (definition, significance,
appraisal) [30] Ongoing training
in critical appraisal of research
literature [23]
Ensure SRs are included in a one-stop-shop that pro-
vides quality-appraised reviews [45]. Add additional
local value to any type of systematic review by using
language that is locally applicable and by engaging in
discussions about the implications of reviews with the
health care managers and policy makers who could po-
tentially act on the reviews’ take-home messages [45].
Identify attributes of the context in which the research
included in a systematic review was conducted to in-
form assessments of the applicability of the review in
other contexts [45]
Collaborative creation of
knowledge in a format that is
easy to view and
comprehensible and allows fast




who expected to use the
reviews in the future
were more likely to
have used a review
than those who did
not expect to use the
reviews [22]
Opportunities for training
and education on systematic
reviews (definition,
significance, appraisal) [30]
Replacing unfamiliar terms or
adding definitions to the re
view [47]. Ensure SRs are
included in a one-stop-shop
that provides quality-appraised
reviews [45]. Add additional
local value to any type of
systematic review by using
language that is locally
applicable and by engaging
in discussions about the
implications of reviews with
the health care managers and
policy-makers who could
potentially act on the reviews’
take-home messages [45]
Involvement of librarians and
health information specialists
as a solution to lack of database
access, establishment of a






of this course into postgraduate
educational curricula, mandatory





on research teams [51]
Provide section on the relevance
of the evidence and the i
ntervention for low and middle
income countries (LMICs) [47].
Ensure SRs are included in a
one-stop-shop that provides
quality-appraised reviews [45]
Involvement in an advisory
role by policy makers on
research teams (i.e. involved
with the development of


















the barrier of not having
enough time to use research
evidence [23]
Make the user-friendly “front end”
of systematic reviews available
through an online database
that could be searched using
keywords that make sense to
health care managers and policy-
makers and that is linked to the
full reviews when they are
available through other sources,
such as The Cochrane Library [45].
Replacing unfamiliar terms or
adding definitions to the
review [47]
Position of end user within
organisation/system: programme
manager vs. director vs. medical





Use of stories to help integration
come alive for participants so
they could see how it lives
operationally [49]. Provide section
on the relevance of the evidence
and the intervention for low and
middle income countries (LMICs)
[47]. Replacing unfamiliar terms
or adding definitions to the
re view [47]
Value the organisation placed
on using research evidence for
decision-making [23]
Make the user-friendly “front end”
of systematic reviews available
through an online database that
could be searched using
keywords that make sense to
health care managers and policy
makers and that is linked to the
full reviews when they are
available through other sources,
such as The Cochrane Library [45].
Provide section on the relevance
of the evidence and the
intervention for low and middle
income countries (LMICs) [47]
Having direct access to online
database searching [23]
Use of stories to help integration
come alive for participants so
they could see how it lives
operationally [49]. Make the
user-friendly “front end” of
systematic reviews available
through an online database that
could be searched using keywords
that make sense to health care
managers and policy makers and
that is linked to the full reviews
when they are available through
other sources, such as The
Cochrane Library [45]
Existence of mechanisms to
facilitate transfer of new
information in health unit [23]
Use of less dense and more
accessible articles [49]. Use of
Reallocate funding away from












Table 3 Facilitators to use of systematic reviews by policy makers and health care managers (Continued)
stories to help integration come
alive for participants so they
could see how it lives
operationally [49]
strategies, fund rapid reviews,
more proactive knowledge
transfer, health care manager
[45]
Removing jargon and using
language that is locally applicable,
engage in discussion about the
potential implications of the
review [45]. It must be packaged
to incite and persuade, “to
translate the evidence into
something that is understandable
by the average legislator, average
citizen” [44]. Concrete
recommendations for practice [31]
Priority of and support for
systematic reviews [51]
It must be packaged to incite and
persuade, “to translate the
evidence into something that is
understandable by the average
legislator, average citizen” [44]
Announce priorities to be
addressed using SR [51]
Use of familiar, non-jargon
language recommended [47].
Removing jargon and using
language that is locally applicable,
engage in discussion about the




Reassurance that no reviews
have been missed [52]. Use
of familiar, non-jargon
language recommended
[47]. Removing jargon and
using language that is
locally applicable, engage
in discussion about the
potential implications of
the review [45]
Consistency in follow-up of
individuals using on-demand
service to appraise and interpret
reviews of research [52]
Easy to use [31]. Framing
the evidence in terms of
how they can implement
it (specifically as a list of









that no reviews have been
missed [52]
Researchers and policy makers
generally found reviews
commissioned through evidence
check to accurately reflect the
state of the evidence, implying
that the requirement for rigour
and comprehensiveness was not
unnecessarily compromised by
the rapid timeframe in which
the reviews were conducted. It
is likely that this is due to both
knowledge brokers’ attempts to
assist in precisely defining the
focus and scope of reviews early












Table 3 Facilitators to use of systematic reviews by policy makers and health care managers (Continued)
and researchers’ depth of
content knowledge and
methodological expertise [41]
Easy to use [31]. Framing the
evidence in terms of how they
can implement it (specifically









Using consistent language and
standard phrases to describe
effect sizes and the quality of
the evidence [47]. Easy to
use [31]
Using consistent language and
standard phrases to describe














Extrinsic factors that were perceived to facilitate use in-
cluded creating collaborations between policy makers
and researchers whereby researchers could provide sys-
tematic reviews of relevance to policy makers in a timely
fashion and facilitate their interpretation [23, 24, 42, 43].
This approach reflects a change in culture for re-
searchers and policy makers/managers. In one of the
intervention studies that were included, resources to im-
plement the research and availability of the systematic
review were identified as facilitators to using them in
decision-making by public health officials [21].
Format features to facilitate use of systematic reviews
Several recommendations from policy makers and health
care managers regarding formatting of systematic re-
views to enhance uptake were identified (Table 4). Many
participants suggested a one-page summary of the re-
view including clear “take home” messages written in
plain language, the publication date of the review, and
sponsoring logos [47, 49]. Some participants recom-
mended that the summary include sections on relevance,
impact, and applicability for decision-makers [45, 47,
52]. They also recommended that the report for the full
review should use a liberal amount of white space with
bullet points (avoiding dense text) and simple tables (less
than one page in length) and consider tailored versions
with targeted key messages for relevant audiences [24].
Another suggestion was to frame the title of the system-
atic review as a question [47].
Content features to facilitate use of systematic reviews
A commonly requested feature amongst the studies was
to frame the evidence in terms of policy application, in-
cluding implications of implementation and potential
outcomes (Table 5) [43, 47, 49]. Participants suggested
that the methods details be minimised to focus on the
critical elements and that the bulk of the report should
focus on the results and interpretation [43, 44, 47]. Ways
to make study quality of included studies easy for users
to interpret, such as providing a graphical summary,
were suggested [44, 47, 52]. Participants also asked that
consistent approaches be used to report effect sizes of
interventions throughout the review report.
Conclusions
We identified several determinants of the use of system-
atic reviews by policy makers and managers including
factors influencing attitudes, knowledge, skills, and
behaviours. For authors of systematic reviews, there are
factors that are potentially modifiable and that may
increase use of systematic reviews including features
affecting format and content. From a format perspective,
review authors can consider providing a one-page summary
with key messages including importance of the topic, key
results, and implications for decision-makers. This sum-
mary should be clearly written and concise. Similarly, the
report for the full review should use white space, avoid
dense text, and try to limit tables to one page. With regard
to content of the reviews, the methods should be concise
and the results should provide an easy to interpret sum-
mary of the risk of bias of individual studies, keeping in
mind that the audience may have limited skills in appraising
the evidence and limited time to do so. The use of a graph-
ical display of the risk of bias, such as the figure advocated
by the Cochrane Collaboration [53] is something review au-
thors should consider using. The discussion should include
the relevance of the results to decision-makers and factors
important for contextualising the evidence. Systematic re-
views should include consideration of what factors influ-
ence contextualisation of the evidence. To make knowledge
more useful to the local context, commissioners of reviews
such as policy makers frequently undertake processes to
contextualise evidence [54], and if guidance on this can be
provided by researchers, this may facilitate the process. For
example, if information is available on how the evidence
might be useful in resource constrained circumstances ver-
sus higher income settings, this should be provided in a sys-
tematic review. To make knowledge more useful to the
local context, commissioners of reviews, such as policy
makers, frequently undertake processes to contextualise
evidence [54], and if guidance on this can be provided by
researchers, this may facilitate their efforts. It was also sug-
gested that the messages be tailored to different audiences,
reflecting their needs. For example, the summary and re-
port that is sent to policy makers would be different from
the one sent to health care managers. These formatting
suggestions should also be considered by journal editors
and publishers to consider enhancing use of reviews. Of
particular importance is the topic addressed by the system-
atic review as several studies raised the concern that the
topics often were not perceived to be relevant by policy
makers and managers. As such, it was suggested that a dif-
ferent approach be undertaken to conduct reviews whereby
partnerships between researchers and decision-makers are
created to ensure that the questions the reviews are tackling
are relevant to the decision-makers. This approach requires
a change in the organisational culture within health care
and research, although there are numerous examples of
successful partnerships like these [4, 5, 55, 56].
Several factors were perceived to influence use of system-
atic reviews that are extrinsic to the review, including a lack
of motivation to use them, lack of awareness, and lack of
skills to seek, appraise, and interpret systematic reviews.
Tackling these challenges could also be addressed by devel-
oping partnerships between researchers and decision-
makers, such as a train the trainer approach whereby
systematic reviewers work with decision-makers to build
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capacity in either conducting reviews or interpreting their
results within their organisation. If researchers can provide
useful systematic reviews and illustrate how they can be
used in a timely fashion to inform decision-making, this
could provide motivation for continued use. Similarly, strat-
egies to enhance awareness of reviews could be enhanced
by these partnerships. Participants also raised the concern
that using a systematic review to guide decision-making led
to a perceived lack of autonomy in decision-making. This
concern has been raised by clinicians for many years in
relation to the practice of evidence-based health care,
reflecting the issue that using evidence implies a “cook-
book” approach to decision-making [57]. It highlights a
misunderstanding around the appropriate use of evi-
dence, whereby the practice of evidence-based health
care requires integration of evidence, expertise, and
values and circumstances [58].
Our results are consistent with systematic reviews of
barriers [29] and facilitators [27] to use of systematic
reviews by any decision-maker. These same authors
also recently published a systematic review of inter-
ventions to increase use of systematic reviews [25].
Oliver and colleagues also published a review of bar-
riers and facilitators to use of evidence by policy
makers; however, their review was not limited to use
of systematic reviews [59]. Search dates for all of these
Table 4 Formatting features of systematic reviews to enhance uptake
Summary Dissemination of SRs Layout, presentation, setup
Summary statement [30] Share material on a website [24, 43] Graded format with key messages [47]
1-page summaries in plain language [49] Provide tailored, targeted messages for
relevant audiences [24]
Recipe type guidance, the information
indicates this, this, and this [52]
Abbreviated format of research evidence,
such as an executive summary, would be
preferable (1 to 2 pages long ) [43]
Electronic communication channels are
generally preferred [43]
Title framed as a question [47]
Expectations of short, clear summary [47] Newsletters containing summaries of
current research developed and directly
emailed to managers [43]
Reformatting the text to make it easier to
pick out important parts [47]
Boxes placed throughout the summaries [47] Chart on first page describing what review
is about [47]
Summary of findings tables [47] Reports could be either distributed
through professional organisations or
through a clearinghouse [43]
A modified academic abstract (relevance
and description of review characteristics
including the impact, applicability to setting,
costs, or other considerations and need for
no further evaluation) [47]
1-page summaries with references, so the
reader is able to investigate further, and case
studies [49]
Active delivery of information (as
opposed to access to online registry) [24]
Preference for less dense, more accessible
literature [49]
Wanted a shorter, clearer presentation [47]
A bullet point evaluation or rating system of
study design quality so that for those of us
who do not make our living doing that, we
do not have to read a half dozen pages to
ferret it out [44]
Develop a more user-friendly “front end” for
potentially relevant systematic reviews (e.g.
1 page of take-home messages and a 3-page
executive summary) to facilitate rapid
assessments of the relevance of a review by
health care managers and policy makers and,
when the review is deemed highly relevant,
more graded entry into the full details of the
review [45]
Well written and concise [47]
Limiting the number of tables and not letting
them break across pages [47]
Simplifying the text and tables and ensuring
that the results in the text matched those in
the tables [47]
Moving partner logos and the summary
publication date to the front page [47]
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systematic reviews were between 2010 and 2012, while
ours was extended to 2014. We found an additional
six to nine studies not included in these reviews.
Moreover, our review focused on factors (and cate-
gorised them) including format and content of the re-
view. Our intent is to use the results of this review to
inform the development of a template for providing
results of systematic reviews to decision-makers and
as such, we wanted to extend the findings of other
reviews to include both intrinsic and extrinsic factors.
Because of this focus, we did not include use of other
types of research evidence beyond systematic reviews
(e.g. results of single studies). Of note, we identified
no additional studies reporting interventions to
increase use of systematic reviews.
There are several limitations to our scoping review.
First, it is a scoping review because we wanted to map
the literature to inform future research on formatting
systematic reviews and to provide guidance for au-
thors of systematic reviews. As such, we did not per-
form risk of bias assessment on individual studies
[32]. Second, most of the studies that were included in
our scoping review were small qualitative studies and
thus their results may not be generalizable. However,
studies from a broad range of countries were included
in our review, and the results are consistent across
studies and previous reviews. Third, the literature
search on this topic is limited by poor indexing of the
primary studies in this area. To overcome this, our
comprehensive search of the databases was supple-
mented by a grey literature search.
This review represents the first phase of a multi-
phase project with is being conducted in partnership
with decision-makers from four provinces in Canada.
The next phases include completing a survey of
perceptions of barriers and facilitators to use of sys-
tematic reviews by policy makers and health care man-
agers in these provinces; integrating the survey and
review results to develop a format for systematic
reviews and test its usability using heuristic and indi-
vidual usability testing; and conducting a randomised
trial to assess a traditional systematic review format
compared with the new format on the ability of health
care managers and policy makers to understand the
Table 5 Content features of systematic review that may increase their use
Decision-making focus Easy to understand Details on included studies
Address relevant policy questions not academic
or business focused questions [44]
Information about the information or meta-
information that tells you what to expect [47]
Provide rating scale for quality of study
design [44]
Clearly articulate the implications of the findings
to public health practice and policy [43]
Include content that was focused on key
findings or the “bottom line” from the study [43]
Include section on the relevance of the
evidence and the intervention for low and
middle income countries (LMICs) [47]
Provide potential short- and long-term
outcomes expected as a result of implementing
the research findings into practice [43]
Provide references to more detailed findings
so the reader is able to investigate further if
needed [49]
Include table describing the characteristics
of the reviews [47]
Policy makers expect content lying outside the
scope of a review: recommendations, outcome
measurements not usually included in a review,
detailed information about local applicability or
costs, and a broader framing of the research
enquiry [47]
Lack features that would make them easier for
government officials to evaluate. For example,
the quality of studies is often difficult for non-
experts to interpret because the explanation of
research methods is long and complicated [44]
Include critical appraisal of included
studies [52]
Frame the evidence in terms of how they
can implement it (specifically as a list of questions
to be considered when developing and
implementing an integrated health system
(which was topic of the review in this study),
information about how to engage stakeholders,
build relationships, and communicate
appropriately across target audiences) [49]
Replace the section for references with a section
for “additional information”: information that
was helpful for understanding the problem, that
provided details about the interventions, or that
put the results of the review in a broader
context [47]
Include bullet point evaluation or rating
system of study design quality so that “for
those of us who don’t make our living doing
that, we do not have to read a half dozen
pages to ferret it out” [44]
It must be packaged to incite and persuade,
“to translate the evidence into something that
is understandable by the average legislator,
average citizen” [44]
Provide table describing the characteristics
of the reviews: makes clear what the review
was looking for [47]
References are clear [47]
Use familiar, non-jargon language [47]
Use consistent language and standard phrases
to describe effect sizes and the quality of the
evidence [47]
Limit the discussion of methods [43]
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evidence in the review and apply it to a relevant health
care decision-making scenario. We have done similar
work to create a format for clinicians and found that it
influences their ability to apply the evidence from a
systematic review to a clinical scenario [20, 60–64].
In summary, we identified common themes across a
variety of studies that explored factors influencing use
of systematic reviews by policy makers and managers.
Useful information has been identified for authors of
systematic reviews to inform their preparation of re-
views including providing one-page summaries with
key messages, tailored to the relevant audience. More-
over, partnerships between researchers and policy
makers/managers to facilitate conduct and use of sys-
tematic reviews should be considered to enhance rele-
vance of reviews and thereby influence uptake. Finally,
these strategies should be rigorously evaluated to deter-
mine impact on reviews.
Additional files
Additional file 1: Literature search strategy used for Medline;
additional search strategies available from the authors.
Additional file 2: Barriers and facilitators to use of systematic
review, categorised by study.
Competing interests
SES is an associate editor of Implementation Science but was not involved
with the peer review process or decision to publish this paper. The rest of
the authors have no competing interests to declare.
Authors’ contributions
ACT conceived the study, screened citations and full-text articles, analysed
and interpreted the data, and wrote the sections of the manuscript. RC and
ST coordinated the study, screened the citations and full-text articles, abstracted
the data, developed qualitative analysis, cleaned, coded and analysed the data,
and edited the manuscript. SM, SES, and MK screened the citations and full-text
articles, abstracted the data, and edited the manuscript. BH, MO, MH, and SS
conceived the study and conceptualised and edited the manuscript. LP
conceived the study, developed the literature search, and conceptualised
and edited the manuscript. SES conceived the study, analysed and interpreted
the data, and wrote and edited the manuscript. All authors read and approved
the final manuscripts.
Acknowledgements
ACT is funded by a CIHR-DSEN New investigator Award, and SES is funded
by a Tier 1 Canada Research Chair. The authors thank Kelly Mrklas for screening
some of the citations for inclusion, Dr. Monika Kastner for providing feedback on
the pilot-test, Becky Skidmore for peer-reviewing and updating our search
strategy, Ana Guzman for formatting the paper, and Alissa Epworth for
obtaining the full-text articles.
Author details
1Knowledge Translation Program, Li Ka Shing Knowledge Institute, St.
Michael’s Hospital, 209 Victoria Street, East Building, Toronto, ON M5B 1W8,
Canada. 2Epidemiology Division, Dalla Lana School of Public Health,
University of Toronto, 155 College Street, Toronto, ON M5T 3M7, Canada.
3Department of Mechanical and Industrial Engineering, University of Toronto,
5 King’s College Road, Toronto, ON M5S 3G8, Canada. 4Departments of
Medicine and Community Health Sciences, University of Calgary, TRW
Building, 3rd Floor, 3280 Hospital Drive NW, Calgary, AB T2N 4Z6, Canada.
5Département de science politique, Pavillon Charles-De Koninck, Université
Laval, Quebec City, Canada. 6Institute of Health Policy, Management and
Evaluation, University of Toronto, Health Sciences Building, 155 College
Street, Suite 425, Toronto, ON M5T 3M6, Canada. 7Research, Evaluation, and
Analysis Branch, Ontario Ministry of Health and Long-Term Care, 80
Grosvenor Street, Toronto, ON M7A 1R3, Canada. 8Nuffield Department of
Population Health, University of Oxford, Richard Doll Building, Old Rd
Campus, Headington, Oxford, Oxfordshire OX3 7LF, UK. 9Department of
Geriatric Medicine, University of Toronto, 27 Kings College Circle, Toronto,
ON M5S 1A1, Canada.
Received: 1 August 2015 Accepted: 6 January 2016
References
1. Cook DJ, Mulrow CD, Haynes RB. Systematic reviews: synthesis of best
evidence for clinical decisions. Ann Intern Med. 1997;126(5):376–80.
2. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of
results of meta-analyses of randomized control trials and recommendations of
clinical experts. Treatments for myocardial infarction. JAMA. 1992;268(2):240–8.
3. Grimshaw JM, Santesso N, Cumpston M, Mayhew A, McGowan J. Knowledge
for knowledge translation: the role of the Cochrane Collaboration. J Contin
Educ Health Prof. 2006;26(1):55–62. doi:10.1002/chp.51.
4. Tricco AC, Soobiah C, Blondal E, Veroniki AA, Khan PA, Vafaei A, et al.
Comparative safety of serotonin (5-HT3) receptor antagonists in patients
undergoing surgery: a systematic review and network meta-analysis.
BMC Med. 2015;13:142. doi:10.1186/s12916-015-0379-3.
5. Tricco AC, Soobiah C, Blondal E, Veroniki AA, Khan PA, Vafaei A, et al.
Comparative efficacy of serotonin (5-HT3) receptor antagonists in patients
undergoing surgery: a systematic review and network meta-analysis.
BMC Med. 2015;13:136. doi:10.1186/s12916-015-0371-y.
6. Graham ID, Logan J, Harrison MB, Straus SE, Tetroe J, Caswell W, et al. Lost
in knowledge translation: time for a map? J Contin Educ Health Prof. 2006;
26(1):13–24. doi:10.1002/chp.47.
7. J. L. Knowledge utilization. What is it? Knowledge: creation, diffusion,
utilization. 1980;1:421–42.
8. Dunn WN. Measuring knowledge use. Knowledge: Creation, diffusion,
utilization. 1983;5:120–33.
9. CH W. The many meanings of research utilization. Public Administration
Rev. 1979:426–31.
10. Beyer JM, Trice HM. The utilization process: a conceptual framework and
synthesis of empirical findings. Admin Sci. 1982;27:591–622.
11. Estabrooks CA. The conceptual structure of research utilization. Res Nurs
Health. 1999;22:203–16.
12. Straus S, Tetroe J, Graham I. Knowledge translation in health care. Oxford:
Wiley Blackwell, BMJ Books; 2013.
13. Oliver K, Lorenc T, Innvaer S. New directions in evidence-based policy
research: a critical analysis of the literature. Health Res Policy Syst. 2014;12:
34. doi:10.1186/1478-4505-12-34.
14. Lavis JN, Ross SE, Hurley JE, Hohenadel JM, Stoddart GL, Woodward CA, et
al. Examining the role of health services research in public policymaking.
Milbank Q. 2002;80(1):125–54.
15. Oxman AD, Lavis JN, Fretheim A. Use of evidence in WHO recommendations.
Lancet. 2007;369(9576):1883–9. doi:10.1016/s0140-6736(07)60675-8.
16. Grol R. Successes and failures in the implementation of evidence-based
guidelines for clinical practice. Med Care. 2001;39(8 Suppl 2):II46–54.
17. Madon T, Hofman KJ, Kupfer L, Glass RI. Public health. Implementation
science. Science. 2007;318(5857):1728–9. doi:10.1126/science.1150009.
18. Canadian Agency for Drugs and Technologies in Health. Systematic review
of use of blood glucose test strips for the management of diabetes mellitus.
2009. https://www.cadth.ca/media/pdf/BGTS_SR_Report_of_Clinical_
Outcomes.pdf. Accessed 10 Jan 2016.
19. Ontario Drug Policy Research Network. Self-monitoring of blood glucose:
patterns, costs and potential cost reduction associated with reduced
testing. 2009. http://www.odprn.ca/research/self-monitoring-of-blood-
glucose/ Accessed 10 Jan 2016.
20. Perrier L, Mrklas K, Lavis JN, Straus SE. Interventions encouraging the use of
systematic reviews by health policymakers and managers: a systematic
review. Implement Sci. 2011;6:43. doi:10.1186/1748-5908-6-43.
21. Ciliska D, Hayward S, Dobbins M, Brunton G, Underwood J. Transferring
public-health nursing research to health-system planning: assessing the
relevance and accessibility of systematic reviews. Can J Nurs Res. 1999;31
(1):23–36.
Tricco et al. Implementation Science  (2016) 11:4 Page 19 of 20
22. Dobbins M, Cockerill R, Barnsley J. Factors affecting the utilization of
systematic reviews. A study of public health decision makers. Int J Technol
Assess Health Care. 2001;17(2):203–14.
23. Dobbins M, Cockerill R, Barnsley J, Ciliska D. Factors of the innovation,
organization, environment, and individual that predict the influence five
systematic reviews had on public health decisions. Int J Technol Assess
Health Care. 2001;17(4):467–78.
24. Dobbins M, Hanna SE, Ciliska D, Manske S, Cameron R, Mercer SL, et al.
A randomized controlled trial evaluating the impact of knowledge
translation and exchange strategies. Implement Sci. 2009;4:61.
doi:10.1186/1748-5908-4-61.
25. Wallace J, Byrne C, Clarke M. Improving the uptake of systematic reviews:
a systematic review of intervention effectiveness and relevance. BMJ Open.
2014;4(10). doi:10.1136/bmjopen-2014-005834.
26. Murthy L, Shepperd S, Clarke MJ, Garner SE, Lavis JN, Perrier L, et al.
Interventions to improve the use of systematic reviews in decision-
making by health system managers, policy makers and clinicians.
Cochrane Database Syst Rev. 2012;9:CD009401. doi:10.1002/14651858.
CD009401.pub2.
27. Wallace J, Byrne C, Clarke M. Making evidence more wanted: a systematic
review of facilitators to enhance the uptake of evidence from systematic
reviews and meta-analyses. Int J Evid Based Healthc. 2012;10(4):338–46.
doi:10.1111/j.1744-1609.2012.00288.x.
28. Ellen ME, Leon G, Bouchard G, Ouimet M, Grimshaw JM, Lavis JN. Barriers,
facilitators and views about next steps to implementing supports for
evidence-informed decision-making in health systems: a qualitative study.
Implement Sci. 2014;9:179. doi:10.1186/s13012-014-0179-8.
29. Wallace J, Nwosu B, Clarke M. Barriers to the uptake of evidence from systematic
reviews and meta-analyses: a systematic review of decision makers’ perceptions.
BMJ Open. 2012;2(5). doi:10.1136/bmjopen-2012-001220.
30. Dobbins M, DeCorby K, Twiddy T. A knowledge transfer strategy for public
health decision makers. Worldviews Evid Based Nurs. 2004;1(2):120–8.
doi:10.1111/j.1741-6787.2004.t01-1-04009.x.
31. Dobbins M, Thomas H, O’Brien MA, Duggan M. Use of systematic reviews in
the development of new provincial public health policies in Ontario. Int J
Technol Assess Health Care. 2004;20(4):399–404.
32. Arksey H, O’Malley L. Scoping studies: towards a methodological framework.
Int J Soc Res Methodol. 2005;8(1):19–32. doi:10.1080/1364557032000119616.
33. Peters MD, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB.
Guidance for conducting systematic scoping reviews. Int J Evid Based
Healthc. 2015. doi:10.1097/xeb.0000000000000050.
34. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for
systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;
339:b2535. doi:10.1136/bmj.b2535.
35. Synthesi.SR. KT Program, Li Ka Shing Knowledge Institute of St. Michael’s
Hospital., Toronto, Ontario, Canada. 2014.
36. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, et al. Why
don’t physicians follow clinical practice guidelines? A framework for
improvement. JAMA. 1999;282(15):1458–65.
37. NVivo qualitative data analysis software; QSR International Pty Ltd. Version
10, 2012. .
38. Albert MA, Fretheim A, Maiga D. Factors influencing the utilization of
research findings by health policy-makers in a developing country: the
selection of Mali’s essential medicines. Health Res Policy Syst. 2007;5:2.
doi:10.1186/1478-4505-5-2.
39. Armstrong R, Pettman T, Burford B, Doyle J, Waters E. Tracking and
understanding the utility of Cochrane reviews for public health decision-
making. J Public Health (Oxf). 2012;34(2):309–13. doi:10.1093/pubmed/
fds038.
40. Atack L, Gignac P, Anderson M. Getting the right information to the table:
using technology to support evidence-based decision making. Healthc
Manage Forum. 2010;23(4):164–8.
41. Campbell D, Donald B, Moore G, Frew D. Evidence check: knowledge
brokering to commission research reviews for policy. Evid Policy. 2011;7(1):
97–107. doi:10.1332/174426411X553034.
42. Campbell DM, Redman S, Jorm L, Cooke M, Zwi AB, Rychetnik L. Increasing
the use of evidence in health policy: practice and views of policy makers
and researchers. Aust New Zealand Health Policy. 2009;6:21. doi:10.1186/
1743-8462-6-21.
43. Dobbins M, Jack S, Thomas H, Kothari A. Public health decision-makers’
informational needs and preferences for receiving research evidence.
Worldviews Evid Based Nurs. 2007;4(3):156–63. doi:10.1111/j.1741-6787.2007.
00089.x.
44. Jewell CJ, Bero LA. “Developing good taste in evidence”: facilitators of and
hindrances to evidence-informed health policymaking in state government.
Milbank Q. 2008;86(2):177–208. doi:10.1111/j.1468-0009.2008.00519.x.
45. Lavis J, Davies H, Oxman A, Denis JL, Golden-Biddle K, Ferlie E. Towards
systematic reviews that inform health care management and policy-making.
J Health Serv Res Policy. 2005;10 Suppl 1:35–48. doi:10.1258/1355819054308549.
46. Ritter A. How do drug policy makers access research evidence? Int J Drug
Policy. 2009;20(1):70–5. doi:10.1016/j.drugpo.2007.11.017.
47. Rosenbaum SE, Glenton C, Wiysonge CS, Abalos E, Mignini L, Young T, et al.
Evidence summaries tailored to health policy-makers in low- and middle-income
countries. Bull World Health Organ. 2011;89(1):54–61. doi:10.2471/blt.10.075481.
48. Shepperd S, Adams R, Hill A, Garner S, Dopson S. Challenges to using evidence
from systematic reviews to stop ineffective practice: an interview study.
J Health Serv Res Policy. 2013;18(3):160–6. doi:10.1177/1355819613480142.
49. Suter E, Armitage GD. Use of a knowledge synthesis by decision makers and
planners to facilitate system level integration in a large Canadian provincial
health authority. Int J Integr Care. 2011;11:e011.
50. Vogel JP, Oxman AD, Glenton C, Rosenbaum S, Lewin S, Gulmezoglu AM, et
al. Policymakers’ and other stakeholders’ perceptions of key considerations
for health system decisions and the presentation of evidence to inform
those considerations: an international survey. Health Res Policy Syst. 2013;
11:19. doi:10.1186/1478-4505-11-19.
51. Yousefi-Nooraie R, Rashidian A, Nedjat S, Majdzadeh R, Mortaz-Hedjri S,
Etemadi A, et al. Promoting development and use of systematic reviews in
a developing country. J Eval Clin Pract. 2009;15(6):1029–34. doi:10.1111/j.
1365-2753.2009.01184.x.
52. Packer C, Hyde C. Does providing timely access to and advice on existing
reviews of research influence health authority purchasing? Public Health
Med. 2000;2(1):20–4.
53. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al.
The Cochrane Collaboration’s tool for assessing risk of bias in randomised
trials. BMJ. 2011;343:d5928. doi:10.1136/bmj.d5928.
54. Wye L, Brangan E, Cameron A, Gabbay J, Klein J, Pope C. Health services
and delivery research. Knowledge exchange in health-care commissioning:
case studies of the use of commercial, not-for-profit and public sector
agencies, 2011–14. Southampton: NIHR Journals Library; 2015.
55. Uneke CJ, Ndukwe CD, Ezeoha AA, Uro-Chukwu HC, Ezeonu CT.
Implementation of a health policy advisory committee as a knowledge
translation platform: the Nigeria experience. Int J Health Policy Manag. 2015;
4(3):161–8. doi:10.15171/ijhpm.2015.21.
56. Lavis JN, Panisset U. EVIPNet Africa’s first series of policy briefs to support
evidence-informed policymaking. Int J Technol Assess Health Care. 2010;
26(02):229–32. doi:10.1017/S0266462310000206.
57. Straus SE, McAlister FA. Evidence-based medicine: a commentary on
common criticisms. CMAJ. 2000;163(7):837–41.
58. Straus SERW, Glasziou P, Haynes RB. Evidence-based medicine: how to
practice and teach EBM. 4th ed. London: Churchill Livingstone; 2010.
59. Oliver K, Innvar S, Lorenc T, Woodman J, Thomas J. A systematic review
of barriers to and facilitators of the use of evidence by policymakers.
BMC Health Services Research. 2014;14(1).
60. Perrier L, Persaud N, Thorpe KE, Straus SE. Using a systematic review in
clinical decision making: a pilot parallel, randomized controlled trial.
Implement Sci. 2015;10:118. doi:10.1186/s13012-015-0303-4.
61. Perrier L, Kealey MR, Straus SE. A usability study of two formats of a
shortened systematic review for clinicians. BMJ Open. 2014;4(12):e005919.
doi:10.1136/bmjopen-2014-005919.
62. Perrier L, Kealey MR, Straus SE. An iterative evaluation of two shortened
systematic review formats for clinicians: a focus group study. JAMIA. 2014;
21(e2):e341–6. doi:10.1136/amiajnl-2014-002660.
63. Perrier L, Persaud N, Ko A, Kastner M, Grimshaw J, McKibbon KA, et al.
Development of two shortened systematic review formats for clinicians.
Implement Sci. 2013;8:68. doi:10.1186/1748-5908-8-68.
64. Perrier L, Mrklas K, Shepperd S, Dobbins M, McKibbon KA, Straus SE.
Interventions encouraging the use of systematic reviews in clinical
decision-making: a systematic review. J Gen Intern Med. 2011;26(4):
419–26. doi:10.1007/s11606-010-1506-7.
Tricco et al. Implementation Science  (2016) 11:4 Page 20 of 20
